Clinical Treatment Score Post-5 Years (CTS5) and Late Recurrence Risk in Hormone Receptor–Positive, HER2-Positive Breast Cancer
- Citation:
- J Natl Compr Canc Netw vol 22 (7) 463-8
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Pharmas:
- Grants:
- U10CA180821, U24 CA196171, UG1CA232760; U10CA180868, UG1CA189867, U10CA180822, U24CA196067 (NRG Oncology)
- Corr. Author:
- Authors:
- Saranya Chumsri Tanmayi Pai Yaohua Ma Zhuo Li Angelica Gil Alvaro Moreno-Aspitia Gerardo Colon-Otero Katherine L. Pogue-Geile Priya Rasgoti Soonmyung Paik Edith A. Perez E. Aubrey Thompson
- Networks:
- LAPS-MN026, NY021, PR028
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- NCCTG-N9831, NSABP B-31
- Phases:
- 3
- Keywords: